Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Epoprostenol
(Veletri, VELETRI)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (Veletri, VELETRI) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
2Epoprostenol FOR injection
(Veletri, VELETRI)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (Veletri, VELETRI) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
3Epoprostenol sodico
(Veletri, VELETRI)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (Veletri, VELETRI) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
4Epoprostenol sodium
(Veletri, VELETRI)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (Veletri, VELETRI) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
5Epoprostenol-actelion
(Veletri, VELETRI)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (Veletri, VELETRI) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
6NEW thermo stable formulation OF epoprostenol sodium
(Veletri, VELETRI)		[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium (Veletri, VELETRI) 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
7Observational study with patients treated with tracleer, ventavis, veletri, opsumit and/or uptravi----[1] 86 💬